Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
P53041
UPID:
PPP5_HUMAN
Alternative names:
Protein phosphatase T
Alternative UPACC:
P53041; Q16722; Q53XV2
Background:
Serine/threonine-protein phosphatase 5 (Protein phosphatase T) plays a pivotal role in dephosphorylating proteins across various signaling pathways, including kinases, nuclear receptors, SMAD proteins, and TAU/MAPT. It is involved in critical cellular processes such as apoptosis, differentiation, DNA damage response, cell survival, and regulation of ion channels, responding to diverse stimuli like hormones, calcium, fatty acids, and oxidative stress.
Therapeutic significance:
Understanding the role of Serine/threonine-protein phosphatase 5 could open doors to potential therapeutic strategies. Its involvement in a wide array of cellular processes and signaling pathways highlights its potential as a target for therapeutic intervention in diseases where these pathways are dysregulated.